Related Experiment Video
Updated: Jul 14, 2026
04:37
Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
Published on: May 23, 2025
Platelet aggregation abnormalities in patients with recurrent fetal losses
Cengiz Beyan1, Kürşat Kaptan, Ahmet Ifran
1Department of Hematology, Gulhane Military Medical Academy, Etlik, 06010 Ankara, Turkey. cbeyan@yahoo.com
Thrombosis Research
|June 9, 2007
Summary
Platelet aggregation abnormalities were not found to be statistically significant in women experiencing recurrent fetal losses. This suggests severe platelet dysfunction is not a primary cause of recurrent pregnancy loss.
Area of Science:
- Hematology
- Reproductive Medicine
- Obstetrics
Background:
- Emerging research suggests a potential role for platelets in recurrent fetal losses.
- Understanding platelet function is crucial for investigating pregnancy complications.
Purpose of the Study:
- To investigate the significance of platelet aggregation abnormalities in patients with recurrent fetal losses.
- To determine if platelet dysfunction is a contributing factor to recurrent pregnancy loss.
Main Methods:
- Compared platelet aggregation in 56 patients with recurrent fetal losses (≥2 or ≥3 losses) against 33 healthy female controls.
- Utilized optical turbidometric method for platelet aggregation studies.
- Tested aggregation response to ADP, collagen, and epinephrine.
Main Results:
- No statistically significant differences in platelet aggregation abnormalities were observed between the recurrent fetal loss group and the control group.
- This finding applies to patients with both ≥2 and ≥3 documented fetal losses.
Conclusions:
- Severe platelet aggregation abnormalities do not appear to be a common characteristic in patients suffering from recurrent fetal losses.
- Further research may be needed to explore other potential causes of recurrent pregnancy loss.
Related Concept Videos
01:22Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
01:16Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:18Structure and Function of Platelets
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.